Efficacy of spinal cord stimulation: uncertain at best

Affiliations

Comment

Sweekriti Sharma et al. Pain. 2020 Oct.

. 2020 Oct;161(10):2428-2429.

doi: 10.1097/j.pain.0000000000001971.

¹ Institute for Musculoskeletal Health, Sydney School of Public Health, Faculty of Medicine and Health, The University of Sydney, New South Wales, Australia.

No abstract available

Comment in

Reply to Sharma et al.
Duarte RV, Nevitt S, McNicol E, Taylor RS, Buchser E, North RB, Eldabe S. Duarte RV, et al. Pain. 2020 Oct;161(10):2429-2430. doi: 10.1097/j.pain.0000000000001972. Pain. 2020. PMID: 32956261 No abstract available.

Systematic review and meta-analysis of placebo/sham controlled randomised trials of spinal cord stimulation for neuropathic pain.
Duarte RV, Nevitt S, McNicol E, Taylor RS, Buchser E, North RB, Eldabe S. Duarte RV, et al. Pain. 2020 Jan;161(1):24-35. doi: 10.1097/j.pain.0000000000001689. Pain. 2020. PMID: 31453983

1. Australian Department of Health-Therapeutic Goods Administration. A document relating to the registration and adverse events for spinal cord stimulators. Available at: https://www.tga.gov.au/sites/default/files/foi-1097-1819-01.pdf. Accessed 2 June, 2020.
1. Duarte RV, McNicol E, Colloca L, Taylor RS, North RB, Eldabe S. Randomized placebo-/sham-controlled trials of spinal cord stimulation: a systematic review and methodological appraisal. Neuromodulation 2020;23:10–8.
1. Duarte RV, Nevitt S, McNicol E, Taylor RS, Buchser E, North RB, Eldabe S. Systematic review and meta-analysis of placebo/sham controlled randomised trials of spinal cord stimulation for neuropathic pain. PAIN 2020;161:24–35.
1. Medtronic. Therapy overview. Available at: https://www.medtronic.com/us-en/patients/treatments-therapies/spinal-cor.... Accessed 2 June, 2020.
1. Mueller PS, Montori VM, Bassler D, Koenig BA, Guyatt GH. Ethical issues in stopping randomized trials early because of apparent benefit. Ann Intern Med 2007;146:878–81.